← all works
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Canadian funderA Canadian agency funded it. The work may carry no Canadian affiliation at all.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- The Lancet Infectious Diseases
- Topic
- Antibiotic Use and Resistance
- Field
- Immunology and Microbiology
- Canadian institutions
- Université LavalCanadian Institutes of Health Research
- Funders
- Merck Sharp and DohmeShionogiPublic Health Agency of CanadaWellcome TrustRocheBiomedical Advanced Research and Development AuthorityInnovative Medicines InitiativeGlaxoSmithKlineWorld Health OrganizationAstraZenecaPfizer
- Keywords
- Antibiotic resistanceAcinetobacter baumanniiEnterococcus faeciumAntibioticsMedicineTigecyclineAcinetobacterMicrobiologyBiologyBacteriaPseudomonas aeruginosa
- Has abstract in OpenAlex
- no